Review
Inflammatory markers in population studies of aging

https://doi.org/10.1016/j.arr.2010.11.002Get rights and content

Abstract

Purpose

To review findings from major epidemiologic studies regarding risk factors for and consequences of elevated markers of inflammation in older adults.

Results

Most large, current epidemiologic studies of older adults have measured serum interleukin-6 (IL-6), C-reactive protein (CRP) and tumor necrosis factor alpha (TNF-alpha) and some studies also include more extensive batteries of measures including soluble receptors. There are few defined risk factors for the modest elevations in inflammatory markers seen with aging. These include visceral adiposity, lower sex steroid hormones, smoking, depression and periodontal disease. Of the markers assessed, IL-6 is most robustly associated with incident disease, disability and mortality.

Conclusion

Though correlated with age, the etiology of elevated inflammatory markers remains incompletely defined. Inflammation, especially IL-6 may be a common cause of multiple age-related diseases or a final common pathway by which disease leads to disability and adverse outcomes in older adults. Future research targeting inflammation should examine these pathways.

Research highlights

► Markers of inflammation are elevated in older adults. ► Visceral abdominal fat and lower sex steroid hormones are associated with higher levels of inflammatory markers. ► Of the markers assessed, IL-6 most robustly predicts disease, disability and mortality in old age.

Introduction

A role for inflammation in the process of aging and age-related disease has been clearly established in several large epidemiologic studies of older adults. Interleukin-6 (IL-6), C-reactive protein (CRP), and tumor necrosis factor alpha (TNF-alpha) are the inflammatory markers most consistently associated with age-related chronic diseases and disability. IL-6 is a cytokine produced by immune cells, vascular endothelial cells, adipocytes and skeletal muscle and has shown to have anti-inflammatory and pro-inflammatory properties (DeRijk et al., 1997, Xing et al., 1998, Maggio et al., 2006b). CRP is an acute phase protein produced by the liver in response to elevations in IL-6. TNF-alpha, another cytokine, is produced mainly by macrophages, but also by lymphoid cells, mast cells, vascular endothelial cells, cardiac myocytes, adipocytes, fibroblasts, and neuronal tissue. TNF-alpha contributes to the production of IL-6 through activation of several pathways (Sawada et al., 1992, Sakamoto et al., 2003, Williams et al., 2008). IL-6 is a major factor driving chronic elevation of CRP in older adults (Roubenoff et al., 1998). Thus, it is not surprising that IL-6, CRP and TNF-alpha are correlated in human population studies.

Acute inflammation is tightly regulated and contributes to the healing process. In younger individuals, cytokine levels are consistently low and typically increase only in response to physiologic stress. In contrast, numerous studies of older adults show that levels of several cytokines, especially IL-6 and TNF-alpha, increase with age even in apparently healthy individuals and in the absence of acute infection (Wei et al., 1992, Ershler et al., 1993, Fagiolo et al., 1993, Cohen et al., 1997, Ferrucci et al., 2005). This age-associated elevation ranges from low to moderate, but is much lower than that seen with acute infection. The etiology of this age-associated increase is not fully understood. Proposed mechanisms include the known increase in total and visceral adiposity with age and declining levels of sex hormones after menopause and andropause. Cumulative oxidative damage, which further invokes an inflammatory response, may be another mechanism leading to an increase in the level of these markers. The consequence of elevated inflammatory markers is better understood. Elevated levels of these cytokines and CRP have been studied extensively as predictors of disease and disability in older adults. White blood cell (WBC) count is also associated with frailty and mortality in older adults (Grimm et al., 1985, Leng et al., 2005, Leng et al., 2007, Leng et al., 2009a, Leng et al., 2009b, Ruggiero et al., 2007), but is not as commonly assessed.

Even after a number of animal and human studies there is still a debate about whether these markers are a direct cause of adverse events or simply summarize the burden of illness in older adults. In this review we summarize results from large epidemiologic studies of older cohorts to illustrate the epidemiological significance of inflammatory markers including IL-6, TNF-alpha and CRP in population studies of aging.

Section snippets

Visceral adiposity and high fat diet

Body fat increases with age with a shift from the periphery to more central abdominal or visceral location. Adipose tissue acts as an active endocrine organ, capable of secreting several cytokines and adipokines, including IL-6 and TNF-alpha (Trayhurn and Wood, 2005). The production of these cytokines may be greater in visceral adipose tissue vs. subcutaneous adipose tissue (Fried et al., 1998, Schrager et al., 2007) and the production rate is variable during the day (Mohamed-Ali et al., 1997).

Cardiovascular disease

While traditional cardiovascular risk factors are useful for predicting incident events in the younger population, their predictive value decreases with age (Beckett et al., 2000). It is possible that absence of inflammatory markers from these models decreases their predictive accuracy in older age groups suggesting a more substantial role of low-grade inflammation in CVD pathogenesis in older adults than in younger adults. In observational studies of older adults, inflammatory markers are

Possible interventions

The strong associations of inflammatory markers with adverse health outcomes in older adults suggest the potential for targeting inflammation to reduce disability and mortality in old age. Advances have been made in targeting TNF and more recently IL-6 in rheumatic conditions, but whether these are relevant in old age is not yet known. Proteasome inhibitors, IL-6 and IL-6 receptor antibodies are in initial testing stages. Indirect evidence for benefit from reducing inflammatory markers in old

Summary

These epidemiologic studies illustrate the significance of inflammatory markers such as IL-6, TNF-alpha and CRP in older adults. These markers increase with age, potentially as a consequence of declining levels of sex hormones and increase in visceral adipose tissue. Given the large burden of chronic disease in older people, it is also quite possible that these elevated markers summarize total disease burden. Of the inflammatory markers studied in cohort studies of aging, IL-6 is most robustly

Acknowledgements

Dr. Singh and Dr. Newman were supported by R01-AG-023629 and R01-AG-030734.

References (165)

  • L. Ferrucci et al.

    Proinflammatory state, hepcidin, and anemia in older persons

    Blood

    (2010)
  • T.B. Harris et al.

    Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly

    Am. J. Med.

    (1999)
  • K. Heikkila et al.

    Systematic review of the association between circulating interleukin-6 (IL-6) and cancer

    Eur. J. Cancer

    (2008)
  • A. Kalogeropoulos et al.

    Inflammatory markers and incident heart failure risk in older adults: the Health ABC (Health, Aging, and Body Composition) study

    J. Am. Coll. Cardiol.

    (2010)
  • E.T. Keller et al.

    Inhibition of NFkappaB activity through maintenance of IkappaBalpha levels contributes to dihydrotestosterone-mediated repression of the interleukin-6 promoter

    J. Biol. Chem.

    (1996)
  • S.X. Leng et al.

    Baseline total and specific differential white blood cell counts and 5-year all-cause mortality in community-dwelling older women

    Exp. Gerontol.

    (2005)
  • S.X. Leng et al.

    Associations of neutrophil and monocyte counts with frailty in community-dwelling disabled older women: results from the Women's Health and Aging Studies I

    Exp. Gerontol.

    (2009)
  • V.M. Martinez-Taboada et al.

    Giant cell arteritis and polymyalgia rheumatica: role of cytokines in the pathogenesis and implications for treatment

    Cytokine

    (2008)
  • M.M. McDermott et al.

    Patterns of inflammation associated with peripheral arterial disease: the InCHIANTI study

    Am. Heart J.

    (2005)
  • J.M. Murabito et al.

    Cross-sectional relations of multiple inflammatory biomarkers to peripheral arterial disease: The Framingham Offspring Study

    Atherosclerosis

    (2009)
  • F. Nappo et al.

    Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals

    J. Am. Coll. Cardiol.

    (2002)
  • H. Nawawi et al.

    Soluble intercellular adhesion molecule-1 and interleukin-6 levels reflect endothelial dysfunction in patients with primary hypercholesterolaemia treated with atorvastatin

    Atherosclerosis

    (2003)
  • R.J. Aviles et al.

    Inflammation as a risk factor for atrial fibrillation

    Circulation

    (2003)
  • M. Barbieri et al.

    Chronic inflammation and the effect of IGF-I on muscle strength and power in older persons

    Am. J. Physiol. Endocrinol. Metab.

    (2003)
  • J.I. Barzilay et al.

    The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study

    Diabetes

    (2001)
  • S. Basaria et al.

    Adverse events associated with testosterone administration

    N. Engl. J. Med.

    (2010)
  • L.E. Beasley et al.

    Inflammation and race and gender differences in computerized tomography-measured adipose depots

    Obesity (Silver Spring)

    (2009)
  • N. Beckett et al.

    Is it advantageous to lower cholesterol in the elderly hypertensive?

    Cardiovasc. Drugs Ther.

    (2000)
  • A.G. Bertoni et al.

    Inflammation and the incidence of type 2 diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA)

    Diabetes Care

    (2010)
  • B.M. Birmann et al.

    Insulin-like growth factor-1- and interleukin-6-related gene variation and risk of multiple myeloma

    Cancer Epidemiol. Biomarkers Prev.

    (2009)
  • W.A. Bretz et al.

    Systemic inflammatory markers, periodontal diseases, and periodontal infections in an elderly population

    J. Am. Geriatr. Soc.

    (2005)
  • H. Bruunsgaard et al.

    Ageing, tumour necrosis factor-alpha (TNF-alpha) and atherosclerosis

    Clin. Exp. Immunol.

    (2000)
  • J.J. Cao et al.

    Association of carotid artery intima-media thickness, plaques, and C-reactive protein with future cardiovascular disease and all-cause mortality: the Cardiovascular Health Study

    Circulation

    (2007)
  • J.A. Cauley et al.

    Inflammatory markers and incident fracture risk in older men and women: the Health Aging and Body Composition Study

    J. Bone Miner. Res.

    (2007)
  • M. Cesari et al.

    C-reactive protein and lipid parameters in older persons aged 80 years and older

    J. Nutr. Health Aging

    (2009)
  • M. Cesari et al.

    Inflammatory markers and onset of cardiovascular events: results from the Health ABC study

    Circulation

    (2003)
  • M. Cesari et al.

    Inflammatory markers and physical performance in older persons: the InCHIANTI study

    J. Gerontol. A: Biol. Sci. Med. Sci.

    (2004)
  • H.J. Cohen et al.

    The association of plasma IL-6 levels with functional disability in community-dwelling elderly

    J. Gerontol. A: Biol. Sci. Med. Sci.

    (1997)
  • H.C. Comijs et al.

    The course of cognitive decline in older persons: results from the longitudinal aging study amsterdam

    Dement. Geriatr. Cogn. Disord.

    (2004)
  • A.J. Cruz-Jentoft et al.

    Understanding sarcopenia as a geriatric syndrome

    Curr. Opin. Clin. Nutr. Metab. Care

    (2010)
  • C.A. Curat et al.

    From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes

    Diabetes

    (2004)
  • M. Cushman et al.

    C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study

    Circulation

    (2005)
  • M. de Lorgeril et al.

    Cholesterol lowering, cardiovascular diseases, and the rosuvastatin-JUPITER controversy: a critical reappraisal

    Arch. Intern. Med.

    (2010)
  • A. Dehghan et al.

    Genetic variation, C-reactive protein levels, and incidence of diabetes

    Diabetes

    (2007)
  • R. DeRijk et al.

    Exercise and circadian rhythm-induced variations in plasma cortisol differentially regulate interleukin-1 beta (IL-1 beta), IL-6, and tumor necrosis factor-alpha (TNF alpha) production in humans: high sensitivity of TNF alpha and resistance of IL-6

    J. Clin. Endocrinol. Metab.

    (1997)
  • C. Ding et al.

    Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study

    J. Clin. Endocrinol. Metab.

    (2008)
  • R. Elosua et al.

    Association between physical activity, physical performance, and inflammatory biomarkers in an elderly population: the InCHIANTI study

    J. Gerontol. A: Biol. Sci. Med. Sci.

    (2005)
  • M.J. Engelhart et al.

    Inflammatory proteins in plasma and the risk of dementia: the rotterdam study

    Arch. Neurol.

    (2004)
  • T.P. Erlinger et al.

    C-reactive protein and the risk of incident colorectal cancer

    JAMA

    (2004)
  • W.B. Ershler et al.

    Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty

    Annu. Rev. Med.

    (2000)
  • Cited by (641)

    • Engagement with nature and proinflammatory biology

      2024, Brain, Behavior, and Immunity
    View all citing articles on Scopus
    View full text